The above free vintage image of DNA strands is courtesy of Shutterstock via Google Images.
Health Friday is a series of posts related to Big Pharma, vaccines, general health, and associated topics. Since today’s post is related to the modRNA COVID-19 “vaccines”, it is dedicated to the memory of Yours Truly’s COVID-19 “vaccinated” late brother, Sam, and to her late cousin Bill; and to all persons, of whatever age or location, who have passed away from the negative effects (direct or indirect) of the COVID-19 “vaccines” that they took.
There are Important Wolf Moon Notifications, the Rules of our late, good Wheatie, and certain Yours Truly caveats, of which readers should be aware. They are linked here. The discussion today is not limited to what is presented below: It is an Open Thread.
Above all — There. Must. Be. Justice.
To Begin: Yours Truly will now change the name of the COVID-19 “vaccines” to reflect what they really are — dangerous and deadly bioweapons injections:
COVID-19 Bioweapon Toxin Injections (COVID-19 BTI). They are NOT “vaccines.” The FDA, the CDC, and the makers of these injections/injectables KNOW THIS. If Yours Truly refers to these injectables as “vaccines”, it is for “convenience-recognition” only, e.g., as in scientific papers or in media headlines.
Today’s post is a confirmation and an amplification regarding the discovery of large amounts of “free” DNA residue in vials of the Pfizer-BioNTech modRNA COVID-19 modRNA BTI, BNT162b2. The trail begins here: https://jessicar.substack.com/p/a-new-paper-confirms-presence-of, A new paper confirms presence of DNA in COVID-19 shot vials, settles issues pertaining to DNA quantification models, shows spike persistence and exosomal shuttling (shedding), by Jessica Rose, PhD., 4 December 2024. Yours Truly will address this article and the paper that it cites, in addition to some earlier papers by other researchers on the topic. The “weave” of today’s post is somewhat dense — the depth of the perfidy behind BNT162b2 is wide and deep. Please bear with me.
The paper to which Dr. Rose refers is here: https://publichealthpolicyjournal.com/biontech-rna-based-covid-19-injections-contain-large-amounts-of-residual-dna-including-an-sv40-promoter-enhancer-sequence/, Ulrike Kammerer et al., 3 December 2024. Read the paper’s title again — there are TWO types of DNA elements in the Pfizer-BioNTech COVID-19 BTI, BNT162b2: what may be called “loose” DNA, plus an SV40 African Green Monkey cancer promoter-enhancer genome code sequence. The salient graphics regarding this from the paper are below:
The Kammerer, et al., paper is hugely important. The multitude of tests and assays that were performed on the samples from the Pfizer-BioNTech modRNA COVID-19 BTI vials is not only incredibly thorough; it is also stunning. Several earlier hypotheses (and evidence from previous scientific papers and articles) regarding these injectables are now confirmed:
One: More of the ingredients of the Pfizer-BioNTech modRNA COVID-19 BTI are confirmed — “loose” DNA; the SV40 African Green Monkey cancer promoter-enhancer genome code sequence; the presence of HEK293 cells (aborted fetal cells); the presence of the antibiotic, Neomycin (a drug that treats bacterial infections); and, ORI replicons in the plasmids in the injectable. ORI replicons are the things that “teach” the “vaccinated” person’s body to make copies of the spike protein — in other words, a type of self-amplifying modRNA mechanism is introduced into the body. Plasmids are tiny DNA molecules that are inside a cell; plasmids are not chromosomal DNA and can independently reproduce themselves. An image of plasmids inside a cell is below (courtesy https://en.wikipedia.org/wiki/Plasmid):
Two: The amount of “loose” DNA in BNT162b2 is well above EMA (European Medicines Agency) limits. A screenshot of Figure 2. section D, of the Kammerer, et al., paper, below, clearly shows this:
Three: The presence of the DNA plasmids and of the SV40 African Green Monkey cancer promoter-enhancer gene code sequence were NOT disclosed to the FDA by Pfizer-BioNTech prior to that agency’s granting of the initial EUA for BNT162b2 on 11 December 2020 for this injectable’s use in the United States. The salient statement from the Kammerer, et al., paper, on this is below:
Yours Truly will note that the FDA also granted “full approval” of BNT162b2 in 2022, under the brand name COMIRNATY, and its “descendant clone” modRNA COVID-19 BTIs, including all “new formula” injections {such as the 2024-2025 COMIRNATY COVID-19 modRNA BTI.)
Four: There is a distinct possibility that BNT162b2 can “shed” from “vaccinated” persons onto other persons, via exosomal secretion. From the Discussion section of the Kammerer, et al., paper, below:
The COVID-19 modRNA BTIs are “shuttled” throughout the body of the person who takes these injectables. This “shuttling”, in part, is performed by exosomes. Exosomes are tiny elements that are formed by lipid bilayers and function as a kind of “shuttle service” within the body, carrying proteins, lipids, and other items to and from body organs, including to the skin. Please refer to: https://pubmed.ncbi.nlm.nih.gov/35436552/, “Innate immune suppression by SARS-CoV-2 mRNA vaccines: The role of G-quadruplexes, exosomes, and MicroRNAs”, Stephanie Seneff, et al., 15 April 2022.
Scientific researchers have been experimenting with SV40 African Green Monkey cancer promoter-enchancer gene code since at least 1997. Please see: https://doi.org/10.1128/JVI.71.1.427-436.1997, “Direct modulation of simian virus 40 late gene expression by thyroid hormone and its receptor”, Fengrong Zuo, Tod Gulick, et al. Below is a graphic of the SV40 gene code experiment, followed by a portion of the Discussion section of this paper:
Research has been performed regarding SV40-induced cancers, via “methylation.” Please refer to: https://doi.org/10.1038/sj.cr.7290295, “Epigenetic changes in virus associated human cancers”, Hsin Pai Li, et al., 1 April 2005.
Two papers by Kevin McKernan have researched much of the information that the Kammerer, et al., paper has confirmed. One McKernan paper is here: https://doi.org/10.31219/osf.io/b9t7m, “Sequencing of bivalent Moderna and Pfizer mRNA vaccines reveals nanogram to microgram quantities of expression vector dsDNA per dose”, Kevin McKernan, et al., 10 April 2023. A graphic from this paper is below:
Please note that there are two separate SV40 elements in this graphic: the SV40 enhancer and the SV40 “signal” in the poly-A “tail” of BNT162b2.
The other McKernan paper is here, regarding DNA fragments in BOTH the Pfizer-BioNTech AND in the Moderna modRNA COVID-19 BTIs: https://doi.org/10.31219/osf.io/mjc97, “DNA fragments detected in monovalent and bivalent Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario, Canada: Exploratory dose relationship with serious adverse events”, Kevin McKernan, et al., 19 October 2023.
Yours Truly now turns to the “primary source document” for BNT162b2, the International Patent declaration document for this injectable. It is found here: https://patents.google.com/patent/WO2021213945A1/en, published on 28 October 2021. Note: The patent number in the Kammerer, et al., paper (WO2021214204) is a another identifier for this patent. It is difficult to access the actual patent document by using this identifier on a search — the above Google URL is easy to find. Another patent number for BNT162b2, WO2021213924, is similarly difficult to find. Yours Truly suspects that these other patent documents and information were “subsumed” into WO2021213945A1.
Yours Truly found listed in the above document, among many other items:
One: That BNT162b2 targets the “vaccinated” person’s CD 4 and CD8 cells. Please see the screenshot, below, from the International Patent declaration:
Two: That BNT162b2 uses ** either ** N1-Methylpseudouridine, or pseudouridine, or 5-methyl-uridine, to replace the natural Uridine in the “vaccinated” person’s body. Please see the screenshot, below, from the International Patent declaration:
The reason why, in Yours Truly’s opinion, there are THREE different types of “fake” Uridine that can be used in BNT262b2 is because Pfizer-BioNTech wanted to have “maximum leeway” to choose any of these three types for use in various formulations and/or lots of BNT162b2. That’s why the words “in one embodiment” are used throughout the patent document. This “leeway” would also theoretically apply to any “descendant clone” modRNA COVID-19 BTI made by this company.
**** Three: Regarding the Kammerer, et al., paper: These researchers used “Sequence ID 16” (SEQ ID 16) in the BNT162b2 International Patent declaration as the basis for their tests and assays regarding the presence of “loose” DNA and the presence of the SV40 African Green Monkey cancer promoter-enhancer gene code piece. Below is a screenshot of the mention of this sequence, and the BNT162b2 patent that was used, by Kammerer, et al.
Yours Truly read through the patent document and found the only area that appears to match SEQ ID 16. A screenshot of this, from the patent document, is below:
From here, Yours Truly found a long list of the actual spike protein gene codes (S protein) in SEQ ID 16. This sequence begins with “hAg-Kozak“, which is important as regards “loose” DNA and the SV40 cancer promoter gene piece code. Please see the screenshot of the hAg-Kozak code, followed by a portion of the spike protein codes, below:
The hAg-Kozak codes are a kind of nucleic acid “pattern” that functions as a “protein initiation site” in mRNA applications (paraphrased from the hAg-Kozak entry at Wikipedia.)
Finally, a screenshot follows of the FI element and Poly-A tail gene codes in SEQ ID 16:
Recall that the Poly-A tail is the “signal” for the SV40 cancer promoter gene code piece in the McKernan paper, cited above.
Our gracious host, Wolf Moon, points out that the FI element is this, per the link here: https://assets.publishing.service.gov.uk/media/65e702542f2b3bd5107cd85f/FOI_22-1116_-_attachment.pdf:
FI element (nucleotides 3864 to 4158): The 3′-UTR is a combination of two sequence elements derived from the “amino terminal enhancer of split” (AES) mRNA (called F) and the mitochondrial encoded 12S ribosomal RNA (called I). These were identified by an ex vivo selection process for sequences that confer RNA stability and augment total protein expression9
Wolf Moon continues: “So basically these are gene sequences that were found to work well as linkers which enhance production of the desired target (the spike protein), and are thus tacked onto the sequence for the spike. IMO they are a lot like the SV40 sequence for DNA, but they work at the mRNA level.”
Further discussion of the TWO separate SV40 cancer promoter elements in BNT162b2 are found in another item cited by the Kammerer, et al., paper: https://anandamide.substack.com/p/pfizer-and-moderna-bivalent-vaccines, “Pfizer and Moderna bivalent vaccines contain 20 – 35% expression vector and are transformation competent in E. coli”, 8 March 2023. A screenshot of their assessment of the SV40 cancer promoter and “signal” placements in BNT162b2 is below:
In Yours Truly’s opinion: What we have here was / is NOT a case of Pfizer-BioNTech saying, “Oops, forgot to remove the loose DNA from BNT162b2 before it was / is put into the vials”; NOR was it / is it, a case of, “Oops, forgot to remove the SV40 elements from the product before it was / is put into the vials.” Instead, it is deliberate inclusion of BOTH the “loose” DNA AND of the SV40 African Green Monkey cancer promoter-enhancer gene code piece into BNT162b2. It says it right there in the International Patent declaration for BNT162b2, the SEQ ID 16 listings. Since BNT162b2 is the basis for the “descendant clone” COVID-19 modRNA BTI by this company, plus the fact that all of these products are manufactured using the “Process 2” method (“marinating” the ingredients of the injectable in E. coli), Yours Truly will posit that it can be assumed that “loose” DNA and the SV40 promoter-enhancer gene codes are present in these “descendant clone” injectables, even if they are present in lesser amounts.
For more information regarding the “shedding” of modRNA COVID-19 BTI, please see: www.theqtree.com/2024/03/25/the-elephant-in-the-room-shedding-of-both-the-covid-19-virus-itself-and-the-covid-19-vaccines/.
For more information on the Process 2 manufacturing method that Pfizer-BioNTech and Moderna use to produce BNT162b2 and mRNA-1273 respectively (and their respective “descendant clone” modRNA COVID-19 BTI), please see: www.theqtree.com/2023/11/06/the-infamous-process-2-manufacturing-method-for-the-pfizer-biontech-moderna-covid-19-vaccines/.
IT IS TIME TO STOP ALL USE OF BNT162b2 (COMIRNATY), OF mRNA-1273 (SPIKEVAX), AND THEIR “2024-2025 FORMULA COVID-19 VACCINES” IMMEDIATELY.
THERE. MUST. BE. JUSTICE.
Peace, Good Energy, Respect: PAVACA